1-4 of 4
Authors: Jason Cole
Journal Article
1283. New Generation Antiviral Conjugate (AVC): Stable, Safe, and Single Open Access
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Pages S656–S657, https://doi.org/10.1093/ofid/ofaa439.1466
Published: 31 December 2020
Journal Article
162. CD377, a Novel Antiviral Fc-conjugate, Demonstrates Potent Viral Burden Reduction Against Influenza a (H1N1) in Mouse and Ferret Models Open Access
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Pages S210–S211, https://doi.org/10.1093/ofid/ofaa439.472
Published: 31 December 2020
Journal Article
1276. Evaluation of CD377, a Novel Antiviral Fc-Conjugate (AVC), In Vitro Activity and In Vivo Efficacy in Immune-Competent and -Deficient (SCID) Lethal Mouse Models Open Access
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Page S654, https://doi.org/10.1093/ofid/ofaa439.1460
Published: 31 December 2020
Journal Article
689. Therapeutic Efficacy of CB-012, a Novel Cloudbreak Antiviral Fc-Conjugate (AVC) in Lethal Mouse Models of Influenza A (H1N1) and Influenza B (Victoria) Open Access
Open Forum Infectious Diseases, Volume 6, Issue Supplement_2, October 2019, Page S313, https://doi.org/10.1093/ofid/ofz360.757
Published: 23 October 2019
